Immutep has sealed a wide-reaching licensing pact with Dr Reddy’s Laboratories, giving the Indian drugmaker exclusive rights to develop and commercialize Eftilagimod Alfa (efti) across most global markets, except North America, Europe, Japan, and...
Biocon Limited has unveiled a major shift. It confirmed plans to fully integrate Biocon Biologics as a wholly owned subsidiary once regulatory and shareholder approvals are cleared. The move marks a pivotal moment for the company as it prepares...
Astrazeneca's presence at the 2025 ASH Annual Meeting is the largest sharpe in the history of ASH and represents Astrazeneca's continuing efforts to lead the way in haematology. The company's 65 abstracts represent an impressive milestone across...
Pharma company Corona Remedies, supported by private equity firm ChrysCapital, has set a price range of Rs 1,008-1,062 per share for its forthcoming Initial Public Offering (IPO), which values the firm at approximately Rs 6,500 crore
The World Health Organization (WHO) has issued its first-ever guideline on using Glucagon-Like Peptide-1 (GLP-1) therapies to treat obesity, recognizing it as a chronic and recurring condition that now affects more than 1 billion people worldwide
Roche’s new pertussis test is now cleared for real?world use in the US, marking a major step for faster, front?line diagnosis of whooping cough and other Bordetella infections.The company stated today that the assay has cleared the FDA 510(k)...
GE HealthCare has revealed that its StarGuide GX system has received CE Mark approval, a state-of-the-art digital 4D SPECT/CT aimed at providing precision, efficiency, and flexibility in molecular imaging
Sun Pharmaceutical Industries introduces its global innovative medication, Ilumya (Tildrakizumab), in India for moderate to severe plaque psoriasis. Ilumya, a new biologic therapy, has been broadly supported by dermatologists in the US
Cloud software leader Veeva Vault CRM is getting a major boost today as Veeva Systems deepens its long-standing partnership with Swiss healthcare powerhouse Roche Pharmaceuticals. The new agreement brings a full global deployment of Veeva’s...
Lupin Human Welfare and Research Foundation (LHWRF), the CSR wing of global pharmaceutical leader Lupin Limited, has earned the top-tier CRISIL Voluntary Organisation rating of VO 1A—a distinction that signifies exceptional program delivery
.jpg)
, CDSCO.jpg)